BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23664757)

  • 1. Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis.
    Hattinger E; Zwicker S; Ruzicka T; Yuspa SH; Wolf R
    Curr Opin Pharmacol; 2013 Aug; 13(4):588-94. PubMed ID: 23664757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function.
    Wolf R; Ruzicka T; Yuspa SH
    Amino Acids; 2011 Oct; 41(4):789-96. PubMed ID: 20596736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis.
    Hegyi Z; Zwicker S; Bureik D; Peric M; Koglin S; Batycka-Baran A; Prinz JC; Ruzicka T; Schauber J; Wolf R
    J Invest Dermatol; 2012 May; 132(5):1416-24. PubMed ID: 22402441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis.
    Batycka-Baran A; Hattinger E; Zwicker S; Summer B; Zack Howard OM; Thomas P; Szepietowski JC; Ruzicka T; Prinz JC; Wolf R
    J Dermatol Sci; 2015 Sep; 79(3):214-21. PubMed ID: 26055798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Friend or Foe?--Psoriasin and Koebnerisin: multifunctional defence molecules in skin differentiation, tumorigenesis and inflammation].
    Zwicker S; Bureik D; Ruzicka T; Wolf R
    Dtsch Med Wochenschr; 2012 Mar; 137(10):491-4. PubMed ID: 22374659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of psoriasin (S100A7) and koebnerisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis.
    Awad SM; Attallah DA; Salama RH; Mahran AM; Abu El-Hamed E
    Clin Exp Dermatol; 2018 Apr; 43(3):262-267. PubMed ID: 29333662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain.
    Jansen S; Podschun R; Leib SL; Grötzinger J; Oestern S; Michalek M; Pufe T; Brandenburg LO
    Infect Immun; 2013 May; 81(5):1788-97. PubMed ID: 23478321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts.
    Gauglitz GG; Bureik D; Zwicker S; Ruzicka T; Wolf R
    Skin Pharmacol Physiol; 2015; 28(3):115-23. PubMed ID: 25502330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
    Vegfors J; Petersson S; Kovács A; Polyak K; Enerbäck C
    PLoS One; 2012; 7(12):e53119. PubMed ID: 23300877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection.
    Andresen E; Lange C; Strodthoff D; Goldmann T; Fischer N; Sahly H; Branscheid D; Heine H
    BMC Pulm Med; 2011 Feb; 11():10. PubMed ID: 21324122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasin (S100A7) and koebserisin (S100A15) as potential markers of atherosclerosis in patients with psoriasis.
    Gonzalez-Cantero A; Gonzalez-Cantero J; Sanchez-Moya AI; Schoendorff-Ortega C; Barderas MG; Perez-Hortet C
    Clin Exp Dermatol; 2019 Mar; 44(2):234. PubMed ID: 30229984
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor binding.
    Murray JI; Tonkin ML; Whiting AL; Peng F; Farnell B; Cullen JT; Hof F; Boulanger MJ
    BMC Struct Biol; 2012 Jul; 12():16. PubMed ID: 22747601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
    Petersson S; Bylander A; Yhr M; Enerbäck C
    BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasin (S100A7) expression is altered during skin tumorigenesis.
    Alowami S; Qing G; Emberley E; Snell L; Watson PH
    BMC Dermatol; 2003 Feb; 3():1. PubMed ID: 12600274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
    Wolf R; Howard OM; Dong HF; Voscopoulos C; Boeshans K; Winston J; Divi R; Gunsior M; Goldsmith P; Ahvazi B; Chavakis T; Oppenheim JJ; Yuspa SH
    J Immunol; 2008 Jul; 181(2):1499-506. PubMed ID: 18606705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene from a psoriasis susceptibility locus primes the skin for inflammation.
    Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH
    Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasin, a multifunctional player in different diseases.
    Jia J; Duan Q; Guo J; Zheng Y
    Curr Protein Pept Sci; 2014; 15(8):836-42. PubMed ID: 25466546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.
    Kurpet K; Chwatko G
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.
    West NR; Farnell B; Murray JI; Hof F; Watson PH; Boulanger MJ
    Protein Sci; 2009 Dec; 18(12):2615-23. PubMed ID: 19844956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.